ERBB4 and colonic neoplasm: Yue et al. found that colon cancer cells display different response to oxaliplatin treatment and LINC00152 antagonize oxaliplatin-induced apoptosis LINC00152 regulates oxaliplatin resistance by sponging miR-193a-3p and then regulates ERBB4 in vitro.